These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7735377)

  • 1. A case of Laron syndrome diagnosed in Slovenia.
    Krzisnik C; Silbergeld A; Laron Z
    J Pediatr Endocrinol; 1994; 7(4):365-9. PubMed ID: 7735377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor-I raises serum procollagen levels in children and adults with Laron syndrome.
    Klinger B; Jensen LT; Silbergeld A; Laron Z
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):423-9. PubMed ID: 8959080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of dwarfism with severely reduced activity of growth hormone-binding protein].
    Igarashi N; Sato T
    Nihon Naibunpi Gakkai Zasshi; 1991 Oct; 67(10):1219-29. PubMed ID: 1752341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone and insulin-like growth factor regulate insulin-like growth factor-binding protein-1 in Laron type dwarfism, growth hormone deficiency and constitutional short stature.
    Laron Z; Suikkari AM; Klinger B; Silbergeld A; Pertzelan A; Seppälä M; Koivisto VA
    Acta Endocrinol (Copenh); 1992 Oct; 127(4):351-8. PubMed ID: 1280392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum GH binding protein activities identifies the heterozygous carriers for Laron type dwarfism.
    Laron Z; Klinger B; Erster B; Silbergeld A
    Acta Endocrinol (Copenh); 1989 Oct; 121(4):603-8. PubMed ID: 2800930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laron-type dwarfism with apparently normal high affinity serum growth hormone-binding protein.
    Buchanan CR; Maheshwari HG; Norman MR; Morrell DJ; Preece MA
    Clin Endocrinol (Oxf); 1991 Aug; 35(2):179-85. PubMed ID: 1934534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The little women of Loja--growth hormone-receptor deficiency in an inbred population of southern Ecuador.
    Rosenbloom AL; Guevara Aguirre J; Rosenfeld RG; Fielder PJ
    N Engl J Med; 1990 Nov; 323(20):1367-74. PubMed ID: 2233903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intronic mutation in the growth hormone (GH) receptor gene from a girl with Laron syndrome and extremely high serum GH binding protein: extended phenotypic study in a very large pedigree.
    Silbergeld A; Dastot F; Klinger B; Kanety H; Eshet R; Amselem S; Laron Z
    J Pediatr Endocrinol Metab; 1997; 10(3):265-74. PubMed ID: 9388817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical profile of Laron dwarfism - experience from a tertiary care institute in Chennai.
    Sethuraman C; Venkatasamy S
    J Pediatr Endocrinol Metab; 2023 May; 36(5):466-469. PubMed ID: 36957988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laron syndrome due to a post-receptor defect: response to IGF-I treatment.
    Laron Z; Klinger B; Eshet R; Kaneti H; Karasik A; Silbergeld A
    Isr J Med Sci; 1993 Dec; 29(12):757-63. PubMed ID: 8300382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced concentration of serum growth hormone-binding protein in children with idiopathic short stature. National Cooperative Growth Study.
    Carlsson LM; Attie KM; Compton PG; Vitangcol RV; Merimee TJ
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1325-30. PubMed ID: 8200933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF binding protein 3 in patients with Laron type dwarfism: effect of exogenous rIGF-I.
    Laron Z; Klinger B; Blum WF; Silbergeld A; Ranke MB
    Clin Endocrinol (Oxf); 1992 Mar; 36(3):301-4. PubMed ID: 1373347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF-I replacement therapy in children with congenital IGF-I deficiency (Laron syndrome) maintains heart dimension and function.
    Scheinowitz M; Feinberg MS; Laron Z
    Growth Horm IGF Res; 2009 Jun; 19(3):280-2. PubMed ID: 19117781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and growth hormone receptor gene mutations of patients with Laron syndrome from a Chinese family.
    Ying YQ; Wei H; Cao LZ; Lu JJ; Luo XP
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):335-8. PubMed ID: 17706034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and hormonal changes induced by one week of administration of rIGF-I to patients with Laron type dwarfism.
    Laron Z; Klinger B; Jensen LT; Erster B
    Clin Endocrinol (Oxf); 1991 Aug; 35(2):145-50. PubMed ID: 1934530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body fat in Laron syndrome patients: effect of insulin-like growth factor I treatment.
    Laron Z; Klinger B
    Horm Res; 1993; 40(1-3):16-22. PubMed ID: 8300045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum prolactin in patients with Laron-type dwarfism: effect of insulin-like growth factor I.
    Silbergeld A; Klinger B; Schwartz H; Laron Z
    Horm Res; 1992; 37(4-5):160-4. PubMed ID: 1490658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of insulin-like growth factor (IGF)-I on serum IGF-I, IGF-binding protein-3 and acid labile subunit in Laron syndrome patients with normal growth hormone binding protein.
    Kanety H; Silbergeld A; Klinger B; Karasik A; Baxter RC; Laron Z
    Eur J Endocrinol; 1997 Dec; 137(6):626-30. PubMed ID: 9437227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism).
    Daughaday WH; Trivedi B
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4636-40. PubMed ID: 3474620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head circumference in untreated and IGF-I treated patients with Laron syndrome: comparison with untreated and hGH-treated children with isolated growth hormone deficiency.
    Laron Z; Iluz M; Kauli R
    Growth Horm IGF Res; 2012 Apr; 22(2):49-52. PubMed ID: 22414926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.